Analysis of the Association Between Changes in the GGT/HDL-C Ratio and the Risk of Diabetes Mellitus Based on a Latent Class Growth Mixed Modeling: A Longitudinal Cohort Study of Adults in China

Overview

Journal Diabetes Metab Syndr Obes

Publisher Dove Medical Press

Specialty Endocrinology

Date 2024 Aug 29

PMID 39206418

Authors

Shichao Liang

Tengfei Yang

Affiliations

Soon will be listed here.

Abstract

Objective: Longitudinal cohort analysis was performed to identify the association between changes in the gamma-glutamyl transferase (GGT)/high-density lipoprotein cholesterol (HDL-C) ratio trajectory and the risk of developing diabetes mellitus.

Methods: This was a retrospective cohort study. We analyzed the latent trajectory classes of changes in the GGT/HDL-C ratio by applying a latent class mixture model with healthy individuals who underwent medical checkups from January 2017 to December 2021 as the study subjects. To analyze the effect of the GGT/HDL-C ratio trajectory classes on new-onset diabetes mellitus, we then applied a multivariate Cox proportional risk regression model. Statistical analysis was performed using the R-software with the LCMM package.

Results: The study cohort comprised 3410 participants. All participants were followed up for 5 years, and 95 developed diabetes (4-year incidence of 2.78%). By applying the latent class mixed model, we categorized participants into three trajectory groups: low-stability group (n = 2253), medium-increase group (n = 941), and high-increase group (n = 216). The Cox proportional risk regression model analysis showed that the hazard ratio (95% confidence interval) for the incidence of diabetes mellitus was 1.73 (1.04-2.87) in the medium-increase group and 3.96 (2.11-7.44) in the high-increase group. Moreover, we calculated the estimated model-based levels and linear slopes of the GGT/HDL-C ratios for each age group between 26 and 85 years at 10-year intervals, respectively. The results indicated the strongest correlation between the GGT/HDL-C ratio slope and diabetes in the 46-55 year age group, with an odds ratio of 1.51 (1.25-1.83).

Conclusion: A large increase in the GGT/HDL-C ratio was highly associated with the risk of developing diabetes mellitus. This result suggests that vigilance for changes in the GGT/HDL-C ratio trajectory during community health screening can help identify potential patients with diabetes, enabling early intervention and treatment.

References

Lawrence J, Divers J, Isom S, Saydah S, Imperatore G, Pihoker C . Trends in Prevalence of Type 1 and Type 2 Diabetes in Children and Adolescents in the US, 2001-2017. JAMA. 2021; 326(8):717-727. PMC: 8385600. DOI: 10.1001/jama.2021.11165. View

Lee D, Jacobs Jr D, Gross M, Kiefe C, Roseman J, Lewis C . Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem. 2003; 49(8):1358-66. DOI: 10.1373/49.8.1358. View

Burro R, Raccanello D, Pasini M, Brondino M . An Estimation of a Nonlinear Dynamic Process Using Latent Class Extended Mixed Models: Affect Profiles After Terrorist Attacks. Nonlinear Dynamics Psychol Life Sci. 2017; 22(1):35-52. View

Xepapadaki E, Nikdima I, Sagiadinou E, Zvintzou E, Kypreos K . HDL and type 2 diabetes: the chicken or the egg?. Diabetologia. 2021; 64(9):1917-1926. DOI: 10.1007/s00125-021-05509-0. View

Nakanishi N, Suzuki K, Tatara K . Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care. 2004; 27(6):1427-32. DOI: 10.2337/diacare.27.6.1427. View

Sturek J, Castle J, Trace A, Page L, Castle A, Evans-Molina C . An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic beta cells. J Clin Invest. 2010; 120(7):2575-89. PMC: 2898593. DOI: 10.1172/JCI41280. View

Whitfield J . Gamma glutamyl transferase. Crit Rev Clin Lab Sci. 2001; 38(4):263-355. DOI: 10.1080/20014091084227. View

Dominguez L, Di Bella G, Veronese N, Barbagallo M . Impact of Mediterranean Diet on Chronic Non-Communicable Diseases and Longevity. Nutrients. 2021; 13(6). PMC: 8231595. DOI: 10.3390/nu13062028. View

Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan B . IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2021; 183:109119. PMC: 11057359. DOI: 10.1016/j.diabres.2021.109119. View

10.

Zhao Y, Xin X, Luo X . The relationship between the ratio of gamma-glutamyltransferase to high-density lipoprotein cholesterol and the risk of diabetes mellitus using publicly available data: a secondary analysis based on a longitudinal study in Japan. Lipids Health Dis. 2023; 22(1):7. PMC: 9843936. DOI: 10.1186/s12944-023-01772-9. View

11.

Yahya R, Jainandunsing S, Rashid M, van der Zee L, Touw A, de Rooij F . HDL associates with insulin resistance and beta-cell dysfunction in South Asian families at risk of type 2 diabetes. J Diabetes Complications. 2021; 35(10):107993. DOI: 10.1016/j.jdiacomp.2021.107993. View

12.

Targher G . Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer - a narrative review. Clin Chem Lab Med. 2009; 48(2):147-57. DOI: 10.1515/CCLM.2010.031. View

13.

Hu H, Han Y, Guan M, Wei L, Wan Q, Hu Y . Elevated gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio has a non-linear association with incident diabetes mellitus: A second analysis of a cohort study. J Diabetes Investig. 2022; 13(12):2027-2037. PMC: 9720204. DOI: 10.1111/jdi.13900. View

14.

Matsuzawa-Nagata N, Takamura T, Ando H, Nakamura S, Kurita S, Misu H . Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism. 2008; 57(8):1071-7. DOI: 10.1016/j.metabol.2008.03.010. View

15.

Li Q, Han Y, Hu H, Zhuge Y . Gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio has a non-linear association with non-alcoholic fatty liver disease: A secondary prospective cohort study in non-obese Chinese adults. Front Med (Lausanne). 2022; 9:995749. PMC: 9712445. DOI: 10.3389/fmed.2022.995749. View

16.

. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024. Diabetes Care. 2023; 47(Suppl 1):S158-S178. PMC: 10725810. DOI: 10.2337/dc24-S009. View

17.

Jayachandran M, Qu S . Harnessing hyperuricemia to atherosclerosis and understanding its mechanistic dependence. Med Res Rev. 2020; 41(1):616-629. DOI: 10.1002/med.21742. View

18.

Shen Y, Wang S, Shen Y, Tan S, Dong Y, Qin W . Evaluating the Usability of mHealth Apps: An Evaluation Model Based on Task Analysis Methods and Eye Movement Data. Healthcare (Basel). 2024; 12(13). PMC: 11241497. DOI: 10.3390/healthcare12131310. View

19.

Athyros V, Doumas M, Imprialos K, Stavropoulos K, Georgianou E, Katsimardou A . Diabetes and lipid metabolism. Hormones (Athens). 2018; 17(1):61-67. DOI: 10.1007/s42000-018-0014-8. View

20.

Feng G, Feng L, Zhao Y . Association between ratio of γ-glutamyl transpeptidase to high-density lipoprotein cholesterol and prevalence of nonalcoholic fatty liver disease and metabolic syndrome: a cross-sectional study. Ann Transl Med. 2020; 8(10):634. PMC: 7290624. DOI: 10.21037/atm-19-4516. View